← Back to Clinical Trials
Recruiting NCT06401148

Exercise-based Cardiac Rehabilitation for Atrial Fibrillation

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Atrial Fibrillation
Sponsor Liverpool John Moores University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 60
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-08-22
Completion 2025-09
Interventions
Cardiac rehab intervention group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The investigators aim to conduct a pilot randomised controlled trial (RCT) with embedded feasibility study to evaluate an exercise-based cardiac rehabilitation (ExCR) programme when delivered to patients with atrial fibrillation on the waiting list for catheter ablation. Our overall objective is to test the feasibility and acceptability of an evidence-based ExCR intervention prior to evaluation in a future randomized controlled trial (RCT).

Eligibility Criteria

Inclusion Criteria: * Participant is willing and able to give informed consent for participation in the study. * Aged ≥18 years. * Diagnosed with AF and on a waiting list or referred for medical treatment for symptomatic AF (eg catheter ablation). * Is eligible and willing to take part in an ExCR programme. Exclusion Criteria: * Blood pressure \>180/100. * Unstable angina. * Severe valvular heart disease as diagnosed by echocardiography. * Heart failure New York Heart Association (NYHA) class 4. * \<6 months post-transplant. * Resting/uncontrolled tachycardia. * Stroke in last 6 weeks. * Cardiac sarcoidosis. * Injury or disability preventing exercise. * Inability to understand trial procedures e.g. difficulties with speaking and understanding the English language.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}